Leaflet DULTAVAX injection suspension
Indicated for: prevention of diphtheria, tetanus and pertussis
Route of administration: injectable
Substance: inactivated polio tetanus diphtheria vaccine (vaccine)
ATC: J07CA01 (Antiinfectives for systemic use | Bacterial and viral vaccines, combined)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The diphtheria, tetanus, inactivated polio (DTP-IPV) vaccine is used to prevent diphtheria, tetanus, and poliomyelitis, three serious infectious diseases caused by bacteria and viruses. The vaccine contains diphtheria and tetanus toxoids, as well as inactivated poliovirus, which stimulate the immune system to produce specific antibodies against these pathogens.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. Booster doses are required at regular intervals to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP-IPV vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.
General data about DULTAVAX
- Substance: inactivated polio tetanus diphtheria vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W42784005
- Pharmaceutical form: injection suspension
- Packing volume: 0,5ml
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.